Basic Information
Cedilla Therapeutics is a protein degradation drug developer that creates targeted small molecules for treating cancer and other diseases. The company's technology focuses on destabilizing cancer protein targets, which are also applicable to therapies beyond oncology, enabling doctors to treat diseases caused by protein dysfunction.
Cedilla Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2018
atellez@cedillatx.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios